Back to Research Hub
Ligand Pharmaceuticals Incorporated
LGND
$243.28+5.53 (+2.33%)
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide.
StreetsValue research for Ligand Pharmaceuticals Incorporated (LGND)
Members get the full report for Ligand Pharmaceuticals Incorporated: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.